02.27.25 -- Take Your Small Molecule Drug Development To The Next Level

Ropack Pharma Solutions provides a serialized supply chain that is proficient, verified and ready to safeguard your pharmaceutical product and the patients who depend on it.

Learn how a partner with comprehensive services can help you reduce development risks, shorten time to market, and navigate complex global regulations with ease.

Lonza's Route Scouting Service empowers biotech partners to overcome the complexities of API development and bring life-changing medicines to market faster.

Discover how our recent investments have expanded our capacity for developing, manufacturing, and packaging highly potent drug products, leveraging over 35 years of expertise.

Find how a collaborative partnership improves flexibility for customers, offers dedicated project teams, and enables a bespoke service that is tailored to each development program.

See how SK pharmteco's innovative La Porte, Texas facility combines advanced technology, sustainability, and strategic efficiency to redefine excellence in pharmaceutical manufacturing.

Ensuring commercial success at every juncture, we employ a consultative and phase-appropriate methodology that's tailored to your specific needs.

Can your product be NanoImproved? Find out with an informational spread covering new molecules and reformulations, small molecules and biologics, technology details, and proof points.

This research demonstrates the potential of high-pressure sterile filtration to enhance efficiency, reduce waste, and accelerate the development of innovative therapies.

Gain insight into the capabilities of our award-winning development and manufacturing facility, which features 10 state-of-the-art GMP manufacturing suites with cutting-edge R&D and QC laboratories.

Our Ascoli facility excels in delivering top-tier OSD medications, empowering partners to deliver groundbreaking treatments that have the potential to transform patients' lives.

At Kymanox, our science-centric CMC team has global experience in strategic planning and authoring regulatory submissions for the pharmaceutical, biologic, and combination product industries.